U2AF1 and myelodysplastic syndrome: Several U2AF1 mutations have been identified in Myelodysplastic Syndrome (MDS) and Lung Adenocarcinoma (LUAD) patients [2], the most common of which is a single missense substitution of serine-34 to phenylalanine (S34F).